Exton, PA, United States of America

Jean F Vollano


Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 72(Granted Patents)


Company Filing History:


Years Active: 1989-1996

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Jean F Vollano: Innovator in Chemotherapeutic Agents

Introduction

Jean F Vollano is a notable inventor based in Exton, PA (US), recognized for his contributions to the field of chemotherapeutic agents. He holds a total of 6 patents, showcasing his innovative approach to cancer treatment.

Latest Patents

Vollano's latest patents include advancements in ruthenium-containing phthalocyanin photosensitizers and anti-tumor platinum complexes. His work on platinum complexes, which exhibit anti-tumor activity, involves the incorporation of at least one functional ketone group or aldehyde. These compounds can be conjugated as linkable hydrazone complexes, allowing for targeted delivery to specific sites or diseases. The functional ketone and aldehyde groups, along with the functionalized hydrazone complexes, can be linked to antibodies, proteins, peptides, and compounds with free amine, hydrazine, or hydrazide functionality. This innovative approach is aimed at enhancing the efficacy of chemotherapeutic agents.

Career Highlights

Throughout his career, Vollano has worked with prominent companies such as Johnson Matthey Inc. and Johnson Matthey Public Limited Company. His experience in these organizations has contributed significantly to his expertise in the development of advanced therapeutic agents.

Collaborations

Vollano has collaborated with esteemed colleagues, including Michael J Abrams and Christen M Giandomenico, who is a talented woman in the field. These collaborations have further enriched his research and development efforts.

Conclusion

Jean F Vollano's innovative work in the field of chemotherapeutic agents highlights his commitment to advancing cancer treatment. His patents and collaborations reflect a dedication to improving targeted therapies for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…